Bionomics Shares In Rally Mode As Investors Take Interest Ahead Of Planned Phase III Trial To Treat PTSD And SAD ($BNOX)
Mobilicom’s Growth Trajectory Steepens As Its Small-Drone Cybersecurity Solutions Earn Global Sales Traction ($MOB)